Tonix Pharmaceuticals (NASDAQ:TNXP) is a research-driven biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines to improve the lives of patients suffering from central nervous system (CNS) disorders, immunology, rare diseases, and infectious diseases. Dedicated to addressing unmet medical needs, Tonix Pharmaceuticals is actively engaged in developing a diverse portfolio of potential therapeutic solutions. Their projects range from preclinical to phase 3 clinical trials, with objectives to provide groundbreaking treatments for conditions lacking effective medications. The company's mission is to advance healthcare by delivering accessible, effective solutions to those in need, underscoring their commitment to innovation and patient care.